The START Center
@thestartcenter
The START Center is a state-of-the-art cancer center with a team of 25 world-class oncologists whose mission is to provide the highest quality of patient care.
ID: 70755686
http://www.thestartcenter.com 01-09-2009 18:57:40
578 Tweet
484 Followers
372 Following
A huge congratulations to our very own Tatiana Hernández for achieving her #PhD today! We are so proud of you & lucky to have you on our team! 🥳
We’re excited to share that Dr. Amita Patnaik has been named to the PharmaVoice 100 list as a “Cancer Care Visionary”! Congratulations, Dr. Patnaik! 🎉 startresearch.com/starts-amita-p…
CEO of the #MaterHospital, Alan Sharp said today: “Given the commitment of START Dublin to accelerate the passage from trials to treatment, this should bring hope to patients, their families and the dedicated oncology team here in the Mater.” Mater Hospital Advanced Cancer Care The START Center
Delighted to have had Minister for Public Expenditure Paschal Donohoe Paschal Donohoe at the #MaterHospital for the official launch of STARTDublin, the Republic of Ireland’s first dedicated Phase I Clinical Trials Unit
Launching STARTDublin, Min. Donohoe said: “It gives me great pleasure to officially open the Republic’s first dedicated Phase I Oncology Clinical Trials Unit... START Dublin will be a vital place to give hope and access to the newest medicines for those with advanced cancer.”
Y por fin una mesa de ensayos clínicos fase 1 en #SEOM24 Muchas gracias por la invitación a participar como moderador - gran discusión sobre los últimos avances. SEOM Fundación Jiménez Díaz The START Center
Exciting news! START’s Dr. Amita Patnaik joins Dr. Shikha Jain MD, FACP on the #OncologyOverdrive podcast. She shares her unique journey in oncology, the critical role of early-phase trials, and START's mission to bring novel treatments to patients. Listen now! tinyurl.com/mpb5sda4
Ireland's 1st Phase 1 Cancer Trials Unit opened Mater Hospital! ➡️Investigational treatments ➡️Free access for eligible patients 🌟A major step forward Austin Duffy Geraldine O'Sullivan Coyne in #CancerResearch STARTDublin The START Center NCCP ESMO - Eur. Oncology Victor Moreno Amita Patnaik
BT7480 Shows Preliminary Activity in Nectin-4+, CD137+ Tumors The START Center @SITCancer #SITC2024 #oncology onclive.com/view/bt7480-sh…
Just presented at #SITC2024 BNT-116 + cemiplimab shows promise in advanced #NSCLC patients previously treated with anti-PD-1: 2 partial Responses. Promising efficacy with manageable safety—exciting progress in #CancerVaccines! @hospital_fjd The START Center
Check out Dr. Victor Moreno's interview with OncLive.com on CLN-619, a novel IgG1 antibody targeting MICA & MICB in solid tumors. In a phase 1 trial, CLN-619 showed immune responses, boosting T-cell & NK cell activity. Listen to Dr. Moreno’s interview: onclive.com/view/dr-moreno…
BT7480, a Nectin-4/CD137 Bicycle tumor–targeted immune cell agonist, showcased clinical activity as a single agent in patients with varying levels of Nectin-4– and CD137-expressing tumors. The START Center @SITCancer #SITC2024 #oncology onclive.com/view/bt7480-sh…
We’re excited to share Victor Moreno's article on how wearables are transforming cancer trials! His findings show that daily walking distance predicts survival better than traditional methods like ECOG. Learn more about this game-changing research: lnkd.in/e4rnQc-V
